Cardiovascular Drugs Global Market Report 2022

Cardiovascular Drugs Global Market Report 2022 – By Type (Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

Name: Cardiovascular Drugs Global Market Report 2022
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Cardiovascular Drugs Global Market Report 2022

Starting Price : $5000.00 $4000.00 | Pages : 300 | Published : March 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

The cardiovascular drugs market consists of sales of cardiovascular drugs by entities (organizations, sole traders and partnerships) that produce cardiovascular drugs to treat cardiovascular diseases. This industry includes establishments that produce anti-hypertensive drugs to prevent heart failure by controlling blood pressure and hypolipidemic drugs that reduce lipid and lipoprotein levels in the blood. It also consists of establishments which produce antithrombotic drugs to treat arterial and venous thrombosis.

The main types of cardiovascular drugs market are anti-hypertensive drugs, hypolipidemics, anti thrombotics, and other drugs for cardiovascular diseases (congestive heart failure, anti-arrhythmic and anti-anginal drugs). Hypolipidemic drugs are a diverse class of medications used to treat high levels of fats (lipids) in the blood, such as cholesterol (hyperlipidemia). The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores, and others.

The global cardiovascular drugs market size is expected to grow from $146.51 billion in 2021 to $153.60 billion in 2022 at a compound annual growth rate (CAGR) of 4.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The cardiovascular drugs market is expected to reach $205.71 billion in 2026 at a CAGR of 7.6%.

The rise in sedentary jobs, busy lifestyles and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of cardiovascular diseases including hypertension. According to the World Health Organization, chronic disease prevalence is rose by 57% globally, in the year 2020. These factors are expected to increase the patient pool globally, thereby driving the cardiovascular drugs market during the forecast period.

High costs associated with drugs is a major issue faced by citizens of many countries. Pressure to contain costs and demonstrate value is widespread. Political uncertainty and persistent economic stress in numerous countries are calling into question the sustainability of public health care funding. In less wealthy countries, lack of cost-effective drugs has influenced the health conditions of the population and has led to a low average life expectancy. As a result, in countries such as Chad, Macedonia, Serbia, the pharmaceutical companies are faced with the pressure of reducing the price of drugs. The high costs associated with drugs are putting pressure on the revenues of cardiovascular drugs market manufacturers.

NOACs are gaining wider acceptance and are replacing traditionally used anti-coagulants such as Warfarin and Heparin. Anti-coagulants have long been used in prevention of thrombus formation in patients suffering with cardiovascular diseases. Use of NOACs makes it easier for patients to continue therapy post discharge as opposed to injections of Heparin and Warfarin which need medical assistance for administration. Some of the NOACs include Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, Xarelto (rivaroxaban) from Janssen, and Eliquis (apixaban) from Bristol-Myers Squibb.

Major companies in the cardiovascular drugs market include Medtronic Inc., Boston Scientific Corporation, Abbott Laboratories, Edwards Lifesciences, Cardinal Health, Inc., Johnson & Johnson, Terumo Corporation, Getinge Group, Teleflex Inc. and Becton Dickinson.

North America was the largest region in the cardiovascular drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the cardiovascular drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cardiovascular drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam.

The global cardiovascular drugs market is segmented -

1) By Type: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs for Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic and Anti-Anginal Drugs)

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others

3) By Route of Administration: Oral, Parenteral, Others

4) By Drug Classification: Branded Drugs, Generic Drugs

5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs

Book your 30 minutes free consultation with our research experts

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

3.1. Market Definition

3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

4.1. Leading Products/ Services

4.2. Key Features and Differentiators

4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

5.1. Supply Chain

5.2. Distribution

5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

6.1. Customer Preferences

6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Impact Of COVID-19 On Cardiovascular Drugs

9. Cardiovascular Drugs Market Size And Growth

9.1. Market Size

9.2. Historic Market Growth, Value ($ Billion)

9.2.1. Drivers Of The Market

9.2.2. Restraints On The Market

9.3. Forecast Market Growth, Value ($ Billion)

9.3.1. Drivers Of The Market

9.3.2. Restraints On The Market

10. Cardiovascular Drugs Market Regional Analysis

10.1. Global Cardiovascular Drugs Market, 2021, By Region, Value ($ Billion)

10.2. Global Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

10.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

11. Cardiovascular Drugs Market Segmentation

11.1. Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Anti-Hypertensive Drugs

Hypolipidemics

Anti Thrombotics

Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

11.2. Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

11.3. Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Oral

Parenteral

Others

11.4. Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Branded Drugs

Generic Drugs

11.5. Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

12. Cardiovascular Drugs Market Metrics

12.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2016-2026, Global

12.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2016-2026, Global

13. Asia-Pacific Cardiovascular Drugs Market

13.1. Asia-Pacific Cardiovascular Drugs Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

13.2. Asia-Pacific, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

13.3. Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

13.4. Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

13.5. Asia-Pacific, Cardiovascular Drugs Market Metrics

13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Asia-Pacific Countries

13.6. Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis

13.7.1. China Cardiovascular Drugs Market

13.7.1.1. China Cardiovascular Drugs Market Overview

13.7.1.2. China Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.1.3. China Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2. Australia Cardiovascular Drugs Market

13.7.2.1. Australia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.2.2. Australia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.3. Hong Kong Cardiovascular Drugs Market

13.7.3.1. Hong Kong Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4. India Cardiovascular Drugs Market

13.7.4.1. India Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.4.2. India Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5. Indonesia Cardiovascular Drugs Market

13.7.5.1. Indonesia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.5.2. Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6. Japan Cardiovascular Drugs Market

13.7.6.1. Japan Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.6.2. Japan Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.7. Malaysia Cardiovascular Drugs Market

13.7.7.1. Malaysia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.8. New Zealand Cardiovascular Drugs Market

13.7.8.1. New Zealand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.9. Philippines Cardiovascular Drugs Market

13.7.9.1. Philippines Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.10. Singapore Cardiovascular Drugs Market

13.7.10.1. Singapore Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11. South Korea Cardiovascular Drugs Market

13.7.11.1. South Korea Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.11.2. South Korea Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.12. Thailand Cardiovascular Drugs Market

13.7.12.1. Thailand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

13.7.13. Vietnam Cardiovascular Drugs Market

13.7.13.1. Vietnam Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14. Western Europe Cardiovascular Drugs Market

14.1. Western Europe Cardiovascular Drugs Market Overview

14.2. Western Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

14.3. Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

14.4. Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

14.5. Western Europe, Cardiovascular Drugs Market Metrics

14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Western Europe Countries

14.6. Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7. Western Europe Cardiovascular Drugs Market: Country Analysis

14.7.1. Austria Cardiovascular Drugs Market

14.7.1.1. Austria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.2. Belgium Cardiovascular Drugs Market

14.7.2.1. Belgium Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.3. Denmark Cardiovascular Drugs Market

14.7.3.1. Denmark Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.4. Finland Cardiovascular Drugs Market

14.7.4.1. Finland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5. France Cardiovascular Drugs Market

14.7.5.1. France Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.5.2. France Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6. Germany Cardiovascular Drugs Market

14.7.6.1. Germany Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.6.2. Germany Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.7. Ireland Cardiovascular Drugs Market

14.7.7.1. Ireland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.8. Italy Cardiovascular Drugs Market

14.7.8.1. Italy Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.9. Netherlands Cardiovascular Drugs Market

14.7.9.1. Netherlands Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.10. Norway Cardiovascular Drugs Market

14.7.10.1. Norway Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.11. Portugal Cardiovascular Drugs Market

14.7.11.1. Portugal Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.12. Spain Cardiovascular Drugs Market

14.7.12.1. Spain Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.13. Sweden Cardiovascular Drugs Market

14.7.13.1. Sweden Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.14. Switzerland Cardiovascular Drugs Market

14.7.14.1. Switzerland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15. UK Cardiovascular Drugs Market

14.7.15.1. UK Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

14.7.15.2. UK Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15. Eastern Europe Cardiovascular Drugs Market

15.1. Eastern Europe Cardiovascular Drugs Market Overview

15.2. Eastern Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

15.3. Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

15.4. Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

15.5. Eastern Europe, Cardiovascular Drugs Market Metrics

15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Eastern Europe Countries

15.6. Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis

15.7.1. Czech Republic Cardiovascular Drugs Market,

15.7.1.1. Czech Republic Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.2. Poland Cardiovascular Drugs Market

15.7.2.1. Poland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.3. Romania Cardiovascular Drugs Market

15.7.3.1. Romania Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4. Russia Cardiovascular Drugs Market

15.7.4.1. Russia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

15.7.4.2. Russia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16. North America Cardiovascular Drugs Market

16.1. North America Cardiovascular Drugs Market Overview

16.2. North America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

16.3. North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

16.4. North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

16.5. North America, Cardiovascular Drugs Market Metrics

16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, North America Countries

16.6. North America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7. North America Cardiovascular Drugs Market: Country Analysis

16.7.1. Canada Cardiovascular Drugs Market

16.7.1.1. Canada Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.2. Mexico Cardiovascular Drugs Market

16.7.2.1. Mexico Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3. USA Cardiovascular Drugs Market

16.7.3.1. USA Cardiovascular Drugs Market Overview

16.7.3.2. USA Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

16.7.3.3. USA Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17. South America Cardiovascular Drugs Market

17.1. South America Cardiovascular Drugs Market Overview

17.2. South America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

17.3. South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

17.4. South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

17.5. South America, Cardiovascular Drugs Market Metrics

17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, South America Countries

17.6. South America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7. South America Cardiovascular Drugs Market: Country Analysis

17.7.1. Argentina Cardiovascular Drugs Market

17.7.1.1. Argentina Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2. Brazil Cardiovascular Drugs Market

17.7.1.1. Brazil Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.2.2. Brazil Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.3. Chile Cardiovascular Drugs Market

17.7.3.1. Chile Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.4. Colombia Cardiovascular Drugs Market

17.7.4.1. Colombia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.5. Peru Cardiovascular Drugs Market

17.7.5.1. Peru Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

17.7.6. Venezuela Cardiovascular Drugs Market

17.7.6.1. Venezuela Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18. Middle East Cardiovascular Drugs Market

18.1. Middle East Cardiovascular Drugs Market Overview

18.2. Middle East, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

18.3. Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

18.4. Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

18.5. Middle East, Cardiovascular Drugs Market Metrics

18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Middle East Countries

18.6. Middle East Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7. Middle East Cardiovascular Drugs Market: Country Analysis

18.7.1. Saudi Arabia Cardiovascular Drugs Market

18.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.2. Israel Cardiovascular Drugs Market

18.7.2.1. Israel Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.3. Turkey Cardiovascular Drugs Market

18.7.3.1. Turkey Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

18.7.4. UAE Cardiovascular Drugs Market

18.7.4.1. UAE Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19. Africa Cardiovascular Drugs Market

19.1. Africa Cardiovascular Drugs Market Overview

19.2. Africa, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

19.3. Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

19.4. Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

19.5. Africa, Cardiovascular Drugs Market Metrics

19.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Africa Countries

19.6. Africa Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7. Africa Cardiovascular Drugs Market: Country Analysis

19.7.1. Egypt Cardiovascular Drugs Market

19.7.1.1. Egypt Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.2. Nigeria Cardiovascular Drugs Market

19.7.2.1. Nigeria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

19.7.3. South Africa Cardiovascular Drugs Market

19.7.3.1. South Africa Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

20. Cardiovascular Drugs Market Competitive Landscape

20.1. Competitive Market Overview

20.2. Market Shares

20.3. Company Profiles

20.3.1. Medtronic Inc

20.3.1.1. Company Overview

20.3.1.2. Products And Services

20.3.1.3. Strategy

20.3.1.4. Financial Performance

20.3.2. Boston Scientific Corporation

20.3.2.1. Company Overview

20.3.2.2. Products And Services

20.3.2.3. Strategy

20.3.2.4. Financial Performance

20.3.3. Abbott Laboratories

20.3.3.1. Company Overview

20.3.3.2. Products And Services

20.3.3.3. Strategy

20.3.3.4. Financial Performance

20.3.4. Edwards Lifesciences

20.3.4.1. Company Overview

20.3.4.2. Products And Services

20.3.4.3. Strategy

20.3.4.4. Financial Performance

20.3.5. Cardinal Health, Inc

20.3.5.1. Company Overview

20.3.5.2. Products And Services

20.3.5.3. Strategy

20.3.5.4. Financial Performance

21. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

22. Market Background: Pharmaceutical Drugs Market

22.1. Pharmaceutical Drugs Market Characteristics

22.2. Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F Growth, By Segment, Value ($ Billion), Global

22.3. Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

22.4. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

22.5. Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

23. Recommendations

23.1. Global Cardiovascular Drugs Market In 2026- Growth Countries

23.2. Global Cardiovascular Drugs Market In 2026- Growth Segments

23.3. Global Cardiovascular Drugs Market In 2026- Growth Strategies

24. Appendix

24.1. NAICS Definitions Of Industry Covered In This Report

24.2. Abbreviations

24.3. Currencies

24.4. Research Inquiries

24.5. The Business Research Company

25. Copyright And Disclaimer

List Of Tables

Table 1: Historic Market Growth, Value ($ Billion)

Table 2: Forecast Market Growth, Value ($ Billion)

Table 3: Global Cardiovascular Drugs Market, 2021, By Region, Value ($ Billion)

Table 4: Global Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 5: Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

Table 6: Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 7: Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 8: Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 9: Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 10: Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Table 11: Cardiovascular Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Table 12: Per Capita Average Cardiovascular Drugs Market Expenditure, 2016-2026, Global

Table 13: Asia-Pacific, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 14: Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 15: Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 16: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Table 17: Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 18: China Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 19: China Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 20: Australia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 21: Australia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 22: Hong Kong Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 23: India Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 24: India Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 25: Indonesia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 26: Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 27: Japan Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 28: Japan Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 29: Malaysia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 30: New Zealand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 31: Philippines Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 32: Singapore Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 33: South Korea Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 34: Thailand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 35: Vietnam Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 36: Western Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 37: Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 38: Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 39: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Western Europe Countries

Table 40: Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 41: Austria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 42: Belgium Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 43: Denmark Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 44: Finland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 45: France Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 46: France Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 47: Germany Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 48: Germany Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 49: Ireland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 50: Italy Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 51: Netherlands Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 52: Norway Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 53: Portugal Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 54: Spain Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 55: Sweden Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 56: Switzerland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 57: UK Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 58: UK Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 59: Eastern Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 60: Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 61: Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 62: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Eastern Europe Countries

Table 63: Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 64: Czech Republic Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 65: Poland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 66: Romania Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 67: Russia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 68: Russia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 69: North America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 70: North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 71: North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 72: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, North America Countries

Table 73: North America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 74: Canada Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 75: Mexico Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 76: USA Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 77: USA Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 78: South America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 79: South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 80: South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 81: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, South America Countries

Table 82: South America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 83: Argentina Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 84: Brazil Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 85: Brazil Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 86: Chile Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 87: Colombia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 88: Peru Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 89: Venezuela Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 90: Middle East, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 91: Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 92: Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 93: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Middle East Countries

Table 94: Middle East Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 95: Saudi Arabia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 96: Israel Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 97: Turkey Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 98: UAE Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 99: Africa, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Table 100: Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Table 101: Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Table 102: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Africa Countries

Table 103: Africa Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 104: Egypt Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 105: Nigeria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 106: South Africa Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Table 107: Medtronic Inc Financial Performance

Table 108: Boston Scientific Corporation Financial Performance

Table 109: Abbott Laboratories Financial Performance

Table 110: Edwards Lifesciences Financial Performance

Table 111: Cardinal Health, Inc Financial Performance

Table 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Table 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Table 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Table 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Table 116: Global Cardiovascular Drugs Market In 2026- Growth Countries

Table 117: Global Cardiovascular Drugs Market In 2026- Growth Segments

Table 118: Global Cardiovascular Drugs Market In 2026- Growth Strategies

List Of Figures

Figure 1: Historic Market Growth, Value ($ Billion)

Figure 2: Forecast Market Growth, Value ($ Billion)

Figure 3: Global Cardiovascular Drugs Market, 2021, By Region, Value ($ Billion)

Figure 4: Global Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 5: Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

Figure 6: Global Cardiovascular Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 7: Global Cardiovascular Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 8: Global Cardiovascular Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 9: Global Cardiovascular Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 10: Global Cardiovascular Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

Figure 11: Cardiovascular Drugs Market Size, Percentage Of GDP, 2016-2026, Global

Figure 12: Per Capita Average Cardiovascular Drugs Market Expenditure, 2016-2026, Global

Figure 13: Asia-Pacific, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 14: Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 15: Asia-Pacific, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 16: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Asia-Pacific Countries

Figure 17: Asia-Pacific Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 18: China Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 19: China Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 20: Australia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 21: Australia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 22: Hong Kong Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 23: India Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 24: India Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 25: Indonesia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 26: Indonesia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 27: Japan Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 28: Japan Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 29: Malaysia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 30: New Zealand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 31: Philippines Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 32: Singapore Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 33: South Korea Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 34: Thailand Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 35: Vietnam Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 36: Western Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 37: Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 38: Western Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 39: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Western Europe Countries

Figure 40: Western Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 41: Austria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 42: Belgium Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 43: Denmark Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 44: Finland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 45: France Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 46: France Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 47: Germany Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 48: Germany Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 49: Ireland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 50: Italy Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 51: Netherlands Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 52: Norway Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 53: Portugal Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 54: Spain Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 55: Sweden Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 56: Switzerland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 57: UK Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 58: UK Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 59: Eastern Europe, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 60: Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 61: Eastern Europe, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 62: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Eastern Europe Countries

Figure 63: Eastern Europe Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 64: Czech Republic Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 65: Poland Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 66: Romania Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 67: Russia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 68: Russia Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 69: North America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 70: North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 71: North America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 72: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, North America Countries

Figure 73: North America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 74: Canada Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 75: Mexico Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 76: USA Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 77: USA Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 78: South America, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 79: South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 80: South America, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 81: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, South America Countries

Figure 82: South America Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 83: Argentina Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 84: Brazil Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 85: Brazil Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 86: Chile Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 87: Colombia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 88: Peru Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 89: Venezuela Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 90: Middle East, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 91: Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 92: Middle East, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 93: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Middle East Countries

Figure 94: Middle East Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 95: Saudi Arabia Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 96: Israel Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 97: Turkey Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 98: UAE Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 99: Africa, Cardiovascular Drugs Market, 2021, By Country, Value ($ Billion)

Figure 100: Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Country

Figure 101: Africa, Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Growth And Market Share Comparison, By Country

Figure 102: Per Capita Average Cardiovascular Drugs Expenditure, 2016-2026, Africa Countries

Figure 103: Africa Cardiovascular Drugs Market, Segmentation By Type, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 104: Egypt Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 105: Nigeria Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 106: South Africa Cardiovascular Drugs Market, 2016-2021, 2021-2026F, 2031F, Value ($ Billion)

Figure 107: Medtronic Inc Financial Performance

Figure 108: Boston Scientific Corporation Financial Performance

Figure 109: Abbott Laboratories Financial Performance

Figure 110: Edwards Lifesciences Financial Performance

Figure 111: Cardinal Health, Inc Financial Performance

Figure 112: Pharmaceutical Drugs Market Historic and Forecast, 2016-2021, 2021-2026F, 2031F, Growth, By Segment, Value ($ Billion), Global

Figure 113: Global Pharmaceutical Drugs Market, 2021, By Region, Value ($ Billion)

Figure 114: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Historic And Forecast, By Region

Figure 115: Global Pharmaceutical Drugs Market, 2016-2021, 2021-2026F, 2031F, Segmentation By Type, Value ($ Billion)

Figure 116: Global Cardiovascular Drugs Market In 2026- Growth Countries

Figure 117: Global Cardiovascular Drugs Market In 2026- Growth Segments

Figure 118: Global Cardiovascular Drugs Market In 2026- Growth Strategies

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

The Biosimilar Therapeutic Peptides Market Share, Market Size, And Growth Rate 2022

Global Anticoagulants Market 2022 – Market Opportunities And Strategies

What Is The Compression Therapy Market Overview In 2022?

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the radiopharmaceuticals market research report 2022 with industry size, share, segments and market growth

Cardiovascular Devices Global Market Report 2024 – By Type (Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anti-Hypertensive Drugs Global Market Report 2024 – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Hypolipidemics Global Market Report 2024 – By Product Type (Cholic Acid Regulator, HMG-CoA Reductase Inhibitors, Adenylate Cyclase Inhibitors, Nicotinic Acid Drugs, Other Types), By Drug Type (Statins, Bile Acid Sequestrants, Cholesterol Absorption Inhibitors, PCSK9 Inhibitors, Other Drug Types), By Application (Hospital, Clinics, Pharmacy, Cardiovasology) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cardiovascular Medical Lasers Global Market Report 2024 – By Type (Excimer Laser, Carbon Dioxide Laser), By Application (Laser Vascular Anastomosis, Transmyocardial Laser Revascularization, Laser Angioplasty For Peripheral Arterial Diseases), By End Use (Hospitals, Specialty Clinics, Ambulatory Surgery Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cardiovascular Monitoring And Diagnostic Devices And Equipment Global Market Report 2024 – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Stress Testing Systems, Event Monitoring Systems, Holter Monitoring Systems), By Type (Heart Disease, Coronary Heart Disease), By End-Use (Hospitals/Physician Clinic (Continuous Glucose Monitors), Home/Emergency, Research and Development (Clinical Trials, Universities, CRO)) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Cardiovascular Surgery Devices And Equipment Global Market Report 2024 – By Product Type (Beating heart surgery systems, Cardiopulmonary Bypass Equipment, Cardiac Ablation Devices, Perfusion Disposables), By Application (Congenital Heart Defects, Cardiac Arrhythmia, Coronary Heart Disease, Congestive Heart Failure, Other Applications), By End User (Home and Ambulatory care, Hospitals, Diagnostic laboratories, Research laboratories) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others), By Route Of Administration (Oral, Parenteral, Others), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (General Pharmacies, Hospital Pharmacies, Online Retailers), By Therapy (Preventive, Curative), By Route Of Administration (Oral, Inhaled, Intravenous, Subcutaneous), By Age Group (Below 5, 5-14, 15-60, Above 60), By Prescription (Prescription, Over The Counter (OTC)), By Drug Type (Branded, Generic) And By Region, Opportunities And Strategies – Global Forecast To 2030

View Report

Frequently Asked Questions

What is the definition of the cardiovascular drugs market?

The cardiovascular drugs market consists of sales of cardiovascular drugs by entities that produce cardiovascular drugs to treat cardiovascular diseases. This industry includes establishments that produce anti-hypertensive drugs to prevent heart failure by controlling blood pressure and hypolipidemic drugs that reduce lipid and lipoprotein levels in the blood. It also consists of establishments which produce antithrombotic drugs to treat arterial and venous thrombosis request a sample here

How will the cardiovascular drugs market drivers and restraints affect cardiovascular drugs market dynamics? What forces will shape the cardiovascular drugs industry going forward?

The cardiovascular drugs market growth is aided by rise in sedentary jobs, busy lifestyles and changing consumer preferences. However, some cardiovascular drugs market restraints include high costs associated with drugs. request a sample here

What is the forecast market size of the cardiovascular drugs market?

The cardiovascular drugs market forecast is expected to reach $107.77 billion in 2025 at a compound annual growth rate of 4%. request a sample here

How is the cardiovascular drugs market segmented?

The global cardiovascular drugs market is segmented -
1) By Type: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
3) By Route Of Administration: Oral, Parenteral, Others
4) By Drug Classification: Branded Drugs, Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs request a sample here

Which region has largest share, and what is the market size and growth by geography according to the cardiovascular drugs global market report?

For more detail on this, request a sample here.

Who are the key players of the global cardiovascular drugs market?

Top competitors in the cardiovascular drugs market are Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG. request a sample here.

What are the key trends in the global cardiovascular drugs market?

Major trends influencing the cardiovascular drugs market include acceptance of NOACs and replacing traditionally used anti-coagulants such as Warfarin and Heparin. request a sample here.

What are the major opportunities in the cardiovascular drugs market and the approaches companies can take to take advantage of them?

For detail on the future and current opportunities in the global cardiovascular drugs market, request a sample here.

How does the cardiovascular drugs market relate to the overall economy and other similar markets?

request a sample here.